img

Global Protein Drugs Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Medical Devices & Consumables Research Center

Publisher : MRX | Format : PDF

Global Protein Drugs Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Protein Drugs Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Protein Drugs industry at home and abroad, estimate the overall market scale of the Protein Drugs industry and the market share of major countries, Protein Drugs industry, and study and judge the downstream market demand of Protein Drugs through systematic research, Analyze the competition pattern of Protein Drugs, so as to help solve the pain points of various stakeholders in Protein Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Protein Drugs Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Protein Drugs Market?
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson&Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen
Major Type of Protein Drugs Covered in XYZResearch report
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes
Application Segments Covered in XYZResearch Market
AIDS
Cancer
Hepatitis
Diabetes
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Protein Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Protein Drugs Market by Value
2.2.1 Global Protein Drugs Revenue by Type
2.2.2 Global Protein Drugs Market by Value (%)
2.3 Global Protein Drugs Market by Production
2.3.1 Global Protein Drugs Production by Type
2.3.2 Global Protein Drugs Market by Production (%)

3. The Major Driver of Protein Drugs Industry
3.1 Historical & Forecast Global Protein Drugs Demand
3.2 Largest Application for Protein Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Protein Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Protein Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Protein Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Protein Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Protein Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Protein Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Protein Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Protein Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Protein Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Protein Drugs Average Price Trend
12.1 Market Price for Each Type of Protein Drugs in US (2018-2022)
12.2 Market Price for Each Type of Protein Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Protein Drugs in China (2018-2022)
12.4 Market Price for Each Type of Protein Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Protein Drugs in India (2018-2022)
12.6 Market Price for Each Type of Protein Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Protein Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Protein Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Protein Drugs

14. Protein Drugs Competitive Landscape
14.1 Eli Lilly
14.1.1 Eli Lilly Company Profiles
14.1.2 Eli Lilly Product Introduction
14.1.3 Eli Lilly Protein Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Abbott Laboratories
14.2.1 Abbott Laboratories Company Profiles
14.2.2 Abbott Laboratories Product Introduction
14.2.3 Abbott Laboratories Protein Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 UCB Group
14.3.1 UCB Group Company Profiles
14.3.2 UCB Group Product Introduction
14.3.3 UCB Group Protein Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Schering-Plough Corporation
14.4.1 Schering-Plough Corporation Company Profiles
14.4.2 Schering-Plough Corporation Product Introduction
14.4.3 Schering-Plough Corporation Protein Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Genentech
14.5.1 Genentech Company Profiles
14.5.2 Genentech Product Introduction
14.5.3 Genentech Protein Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Johnson&Johnson
14.6.1 Johnson&Johnson Company Profiles
14.6.2 Johnson&Johnson Product Introduction
14.6.3 Johnson&Johnson Protein Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Bristol-Myers Squibb
14.7.1 Bristol-Myers Squibb Company Profiles
14.7.2 Bristol-Myers Squibb Product Introduction
14.7.3 Bristol-Myers Squibb Protein Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Novo Nordisk
14.8.1 Novo Nordisk Company Profiles
14.8.2 Novo Nordisk Product Introduction
14.8.3 Novo Nordisk Protein Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Biogen Idec
14.9.1 Biogen Idec Company Profiles
14.9.2 Biogen Idec Product Introduction
14.9.3 Biogen Idec Protein Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Dendreon Corporation
14.10.1 Dendreon Corporation Company Profiles
14.10.2 Dendreon Corporation Product Introduction
14.10.3 Dendreon Corporation Protein Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Amgen
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Protein Drugs Industry (Volume)
Figure 2. Protein Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Protein Drugs Revenue in 2022
Figure 5. US Protein Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Protein Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Protein Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Protein Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Protein Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Protein Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Protein Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Protein Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Protein Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Protein Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Protein Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Protein Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Protein Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Protein Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Protein Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Protein Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Protein Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Protein Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Protein Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Protein Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Eli Lilly Profiles
Table 61. Eli Lilly Protein Drugs Product Introduction
Table 62. Eli Lilly Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Eli Lilly Strategic initiatives
Table 64. Abbott Laboratories Profiles
Table 65. Abbott Laboratories Protein Drugs Product Introduction
Table 66. Abbott Laboratories Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Abbott Laboratories Strategic initiatives
Table 68. UCB Group Profiles
Table 69. UCB Group Protein Drugs Product Introduction
Table 70. UCB Group Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. UCB Group Strategic initiatives
Table 72. Schering-Plough Corporation Profiles
Table 73. Schering-Plough Corporation Protein Drugs Product Introduction
Table 74. Schering-Plough Corporation Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Schering-Plough Corporation Strategic initiatives
Table 76. Genentech Profiles
Table 77. Genentech Protein Drugs Product Introduction
Table 78. Genentech Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Genentech Strategic initiatives
Table 80. Johnson&Johnson Profiles
Table 81. Johnson&Johnson Protein Drugs Product Introduction
Table 82. Johnson&Johnson Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Johnson&Johnson Strategic initiatives
Table 84. Bristol-Myers Squibb Profiles
Table 85. Bristol-Myers Squibb Protein Drugs Product Introduction
Table 86. Bristol-Myers Squibb Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Bristol-Myers Squibb Strategic initiatives
Table 88. Novo Nordisk Profiles
Table 89. Novo Nordisk Protein Drugs Product Introduction
Table 90. Novo Nordisk Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Novo Nordisk Strategic initiatives
Table 92. Biogen Idec Profiles
Table 93. Biogen Idec Protein Drugs Product Introduction
Table 94. Biogen Idec Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Biogen Idec Strategic initiatives
Table 97. Dendreon Corporation Profiles
Table 98. Dendreon Corporation Protein Drugs Product Introduction
Table 99. Dendreon Corporation Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Dendreon Corporation Strategic initiatives
Table 101. Amgen Profiles
Table 102. Amgen Protein Drugs Product Introduction
Table 103. Amgen Protein Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Amgen Strategic initiatives